{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:23:27Z","timestamp":1788557007992,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Meclizine is a well-tolerated drug routinely used as an anti-histamine agent in the management of disequilibrium. Recently, meclizine has been assessed for its neuroprotective properties in ischemic stroke and Huntington disease models. We found that meclizine protected against 6-hydroxydopamine-induced apoptosis and cell death in both SH-SY5Y cells and rat primary cortical cultures. Meclizine increases the level of 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 (PFKFB3), which activates phosphofructokinase, a rate-determining enzyme of glycolysis. This protection is therefore mediated by meclizine\u2019s ability to enhance glycolysis and increase mitochondrial hyperpolarization. Meclizine represents an interesting candidate for further investigation to re-purpose for its potential to be neuroprotective in Parkinson disease.<\/jats:p>","DOI":"10.1038\/srep25344","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T09:08:28Z","timestamp":1462439308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models"],"prefix":"10.1038","volume":"6","author":[{"given":"Chien Tai","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yin","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H. V.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,5]]},"reference":[{"key":"BFsrep25344_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 5, 525\u2013535, 10.1016\/S1474-4422(06)70471-9 (2006).","journal-title":"Lancet Neurol."},{"key":"BFsrep25344_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/bmj.3.5776.690","volume":"3","author":"PD Lewis","year":"1971","unstructured":"Lewis, P. D. Parkinsonism\u2014neuropathology. Br Med J. 3, 690\u2013692 (1971).","journal-title":"Br Med J."},{"key":"BFsrep25344_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.21667","volume":"23","author":"S Rahman","year":"2008","unstructured":"Rahman, S. et al. Quality of life in Parkinson\u2019s disease: the relative importance of the symptoms. Mov Disord. 23, 1428\u20131434, 10.1002\/mds.21667 (2008).","journal-title":"Mov Disord."},{"key":"BFsrep25344_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker Jr.","year":"2008","unstructured":"Parker, W. D. Jr ., Parks, J. K. & Swerdlow, R. H. Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res. 1189, 215\u2013218, 10.1016\/j.brainres.2007.10.061 (2008).","journal-title":"Brain Res."},{"key":"BFsrep25344_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"333","author":"AH Schapira","year":"1989","unstructured":"Schapira, A. H. et al. Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 333, 1269, 10.1016\/S0140-6736(89)92366-0 (1989).","journal-title":"Lancet"},{"key":"BFsrep25344_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira, A. H. Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol. 7, 97\u2013109, 10.1016\/S1474-4422(07)70327-7 (2008).","journal-title":"Lancet Neurol."},{"key":"BFsrep25344_CR7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann, A. et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. PNAS 97, 2875\u20132880, 10.1073\/pnas.040556597 (2000).","journal-title":"PNAS"},{"key":"BFsrep25344_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1046\/j.1471-4159.2001.00160.x","volume":"76","author":"A Hartmann","year":"2001","unstructured":"Hartmann, A. et al. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease? J. Neurochem. 76(6), 1785\u20131793, 10.1046\/j.1471-4159.2001.00160.x (2001).","journal-title":"J. Neurochem."},{"key":"BFsrep25344_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s007020050028","volume":"107","author":"M Mogi","year":"2000","unstructured":"Mogi, M. et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural Transm. 107(3), 335\u2013341 (2000).","journal-title":"J. Neural Transm."},{"key":"BFsrep25344_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/exnr.2000.7489","volume":"166","author":"NA Tatton","year":"2000","unstructured":"Tatton, N. A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson\u2019s disease. Exp. Neurol. 166, 29\u201343, 10.1006\/exnr.2000.7489 (2000).","journal-title":"Exp. Neurol."},{"key":"BFsrep25344_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.bbabio.2006.03.017","volume":"1757","author":"Y Tsujimoto","year":"2006","unstructured":"Tsujimoto, Y., Nakagawa, T. & Shimizu, S. Mitochondrial membrane permeability transition and cell death. Biochim. Biophys. Acta 1757, 1297\u20131300, 10.1016\/j.bbabio.2006.03.017 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep25344_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","volume":"11","author":"S Bonnet","year":"2007","unstructured":"Bonnet, S. et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37\u201351, 10.1016\/j.ccr.2006.10.020 (2007).","journal-title":"Cancer Cell"},{"key":"BFsrep25344_CR13","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1158\/0008-5472.CAN-05-2444","volume":"65","author":"BG Heerdt","year":"2005","unstructured":"Heerdt, B. G., Houston, M. A. & Augenlicht, L. H. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res. 65(21), 9861\u20137, 10.1158\/0008-5472.CAN-05-2444 (2005).","journal-title":"Cancer Res."},{"key":"BFsrep25344_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0006-8993(02)03695-8","volume":"962","author":"E Mazzio","year":"2003","unstructured":"Mazzio, E. & Soliman, K. F. D-(+)-glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells. Brain Res. 962, 48\u201360, 10.1016\/S0006-8993(02)03695-8 (2003).","journal-title":"Brain Res."},{"key":"BFsrep25344_CR15","doi-asserted-by":"publisher","first-page":"e19191","DOI":"10.1371\/journal.pone.0019191","volume":"6","author":"JT Newington","year":"2011","unstructured":"Newington, J. T. et al. Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLos. One. 6, e19191, 10.1371\/journal.pone.0019191 (2011).","journal-title":"PLos. One."},{"key":"BFsrep25344_CR16","doi-asserted-by":"publisher","first-page":"37245","DOI":"10.1074\/jbc.M112.366195","volume":"287","author":"JT Newington","year":"2012","unstructured":"Newington, J. T. et al. Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid beta and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. J. Biol. Chem. 287, 37245\u201337258, 10.1074\/jbc.M112.366195 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep25344_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s11064-006-9276-7","volume":"32","author":"ZR Williams","year":"2007","unstructured":"Williams, Z. R., Goodman, C. B. & Soliman, K. F. Anaerobic glycolysis protection against 1-methy-4-phenylpyridinium (MPP+) toxicity in C6 glioma cells. Neurochem. Res. 32, 1071\u20131080, 10.1007\/s11064-006-9276-7 (2007).","journal-title":"Neurochem. Res."},{"key":"BFsrep25344_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nbt.1606","volume":"28","author":"VM Gohil","year":"2010","unstructured":"Gohil, V. M. et al. Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat. Biotechnol. 28, 249\u2013255, 10.1038\/nbt.1606 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFsrep25344_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/hmg\/ddq464","volume":"20","author":"VM Gohil","year":"2011","unstructured":"Gohil, V. M. et al. Meclizine is neuroprotective in models of Huntington\u2019s disease. Hum. Mol. Genet. 20, 294\u2013300, 10.1093\/hmg\/ddq464 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep25344_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/j.1471-4159.2007.05115.x","volume":"104","author":"M Gomez-Lazaro","year":"2008","unstructured":"Gomez-Lazaro, M. et al. 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J. Neurochem. 104, 10.1111\/j.1471-4159.2007.05115.x 1599\u2013161 (2008).","journal-title":"J. Neurochem."},{"key":"BFsrep25344_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2007.04.028","volume":"43","author":"SM Kulich","year":"2007","unstructured":"Kulich, S. M., Horbinski, C., Patel, M. & Chu, C. T. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic. Biol. Med. 43, 372\u2013383, 10.1016\/j.freeradbiomed.2007.04.028 (2007).","journal-title":"Free Radic. Biol. Med."},{"key":"BFsrep25344_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer, G., Galluzzi, L. & Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 87, 99\u2013163, 10.1152\/physrev.00013.2006 (2007).","journal-title":"Physiol Rev."},{"key":"BFsrep25344_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tibs.2009.10.006","volume":"35","author":"JP Bolanos","year":"2010","unstructured":"Bolanos, J. P., Almeida, A. & Moncada, S. Glycolysis: a bioenergetic or a survival pathway? Trends Biochem. Sci. 35, 145\u2013149, 10.1016\/j.tibs.2009.10.006 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"BFsrep25344_CR24","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.1073\/pnas.261560998","volume":"98","author":"A Almeida","year":"2001","unstructured":"Almeida, A., Almeida, J., Bola\u00f1os, J. P. & Moncada, S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. PNAS 98, 15294\u201315299, 10.1073\/pnas.261560998 (2001).","journal-title":"PNAS"},{"key":"BFsrep25344_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cell.2012.12.029","volume":"152","author":"D Zala","year":"2013","unstructured":"Zala, D. et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152, 479\u201391, 10.1016\/j.cell.2012.12.029 (2013).","journal-title":"Cell"},{"key":"BFsrep25344_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","volume":"1337","author":"FM Lopes","year":"2010","unstructured":"Lopes, F. M. et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res. 1337, 85\u201394, 10.1016\/j.brainres.2010.03.102 (2010).","journal-title":"Brain Res."},{"key":"BFsrep25344_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tiv.2005.01.006","volume":"19","author":"MA Tirmenstein","year":"2005","unstructured":"Tirmenstein, M. A. et al. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol. In Vitro 19, 471\u2013479, 10.1016\/j.tiv.2005.01.006 (2005).","journal-title":"Toxicol. In Vitro"},{"key":"BFsrep25344_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.04.037","volume":"72","author":"G Tovilovic","year":"2013","unstructured":"Tovilovic, G. et al. Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death. Neuropharmacology 72, 224\u2013235, 10.1016\/j.neuropharm.2013.04.037 (2013).","journal-title":"Neuropharmacology"},{"key":"BFsrep25344_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2008.11.012","volume":"278","author":"KY Chau","year":"2009","unstructured":"Chau, K. Y., Korlipara, L. V., Cooper, J. M. & Schapira, A. H. Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors. J. Neurol. Sci. 278, 44\u201353, 10.1016\/j.jns.2008.11.012 (2009).","journal-title":"J. Neurol. Sci."},{"key":"BFsrep25344_CR30","doi-asserted-by":"publisher","first-page":"803930","DOI":"10.1155\/2012\/803930","volume":"2012","author":"SY Xu","year":"2012","unstructured":"Xu, S. Y. et al. A modified technique for culturing primary fetal rat cortical neurons., J. Biomed. Biotechnol. 2012, 803930, 10.1155\/2012\/803930 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"BFsrep25344_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neuint.2010.06.017","volume":"57","author":"KY Chau","year":"2010","unstructured":"Chau, K. Y., Cooper, J. M. & Schapira, A. H. Rasagne protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells. Neurochem. Int. 57, 525\u20139, 10.1016\/j.neuint.2010.06.017 (2010).","journal-title":"Neurochem. Int."},{"key":"BFsrep25344_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","volume":"62","author":"MW Cleeter","year":"2013","unstructured":"Cleeter, M. W. et al. Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage. Neurochem. Int. 62, 1\u20137, 10.1016\/j.neuint.2012.10.010 (2013).","journal-title":"Neurochem. Int."},{"key":"BFsrep25344_CR33","first-page":"35","volume":"361","author":"MR Duchen","year":"2003","unstructured":"Duchen, M. R., Surin, A. & Jacobson, J. Imaging mitochondrial function in intact cells. Methods Enzymol. 361, 35\u2013389 (2003).","journal-title":"Methods Enzymol."},{"key":"BFsrep25344_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","volume":"33","author":"S Gandhi","year":"2009","unstructured":"Gandhi, S. et al. PINK1-associated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell 33, 627\u2013638, 10.1016\/j.molcel.2009.02.013 (2009).","journal-title":"Mol. Cell"},{"key":"BFsrep25344_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cyto.a.20198","volume":"69","author":"WJ Koopman","year":"2006","unstructured":"Koopman, W. J., Visch, H. J., Smeitink, J. A. & Willems, P. H. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A 69, 1\u201312, 10.1002\/cyto.a.20198 (2006).","journal-title":"Cytometry A"},{"key":"BFsrep25344_CR36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1471-4159.2004.02804.x","volume":"91","author":"M Gu","year":"2004","unstructured":"Gu, M. et al. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J. Neurochem. 91, 1075\u20131081, 10.1111\/j.1471-4159.2004.02804.x (2004).","journal-title":"J. Neurochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep25344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25344","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T04:24:37Z","timestamp":1672892677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep25344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,31]]}},"alternative-id":["BFsrep25344"],"URL":"https:\/\/doi.org\/10.1038\/srep25344","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,5]]},"assertion":[{"value":"5 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25344"}}